Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,008 | 7 | 52.8% |
| Food and Beverage | $6,998 | 529 | 46.1% |
| Travel and Lodging | $114.17 | 5 | 0.8% |
| Education | $46.91 | 1 | 0.3% |
| Gift | $13.29 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Avanir Pharmaceuticals, Inc. | $8,628 | 39 | $0 (2022) |
| Lundbeck LLC | $1,599 | 124 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,288 | 152 | $0 (2022) |
| Validus Pharmaceuticals LLC | $511.29 | 11 | $0 (2021) |
| Allergan, Inc. | $368.92 | 35 | $0 (2020) |
| Otsuka America Pharmaceutical, Inc. | $330.48 | 19 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $284.95 | 27 | $0 (2020) |
| Neuronetics, Inc. | $250.38 | 6 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $239.77 | 24 | $0 (2020) |
| ABBVIE INC. | $231.80 | 17 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $206.72 | 16 | Lundbeck LLC ($180.26) |
| 2023 | $242.71 | 16 | Lundbeck LLC ($147.44) |
| 2022 | $508.94 | 25 | Neuronetics, Inc. ($109.79) |
| 2021 | $1,302 | 63 | Validus Pharmaceuticals LLC ($378.26) |
| 2020 | $1,105 | 85 | Sunovion Pharmaceuticals Inc. ($358.26) |
| 2019 | $1,176 | 108 | Sunovion Pharmaceuticals Inc. ($298.77) |
| 2018 | $2,391 | 108 | Avanir Pharmaceuticals, Inc. ($1,280) |
| 2017 | $8,248 | 122 | Avanir Pharmaceuticals, Inc. ($7,167) |
All Payment Transactions
543 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $11.62 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.97 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.26 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.33 | General |
| Category: PSYCHIATRY | ||||||
| 07/23/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.04 | General |
| Category: PSYCHIATRY | ||||||
| 07/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $11.53 | General |
| Category: PSYCHIATRY | ||||||
| 06/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $11.88 | General |
| Category: PSYCHIATRY | ||||||
| 06/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.69 | General |
| Category: PSYCHIATRY | ||||||
| 05/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: PSYCHIATRY | ||||||
| 05/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $7.22 | General |
| Category: PSYCHIATRY | ||||||
| 05/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $1.94 | General |
| Category: PSYCHIATRY | ||||||
| 04/08/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $6.16 | General |
| Category: PSYCHIATRY | ||||||
| 03/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $10.34 | General |
| Category: PSYCHIATRY | ||||||
| 03/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $10.82 | General |
| Category: PSYCHIATRY | ||||||
| 02/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $11.30 | General |
| Category: PSYCHIATRY | ||||||
| 01/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.16 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.63 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), REXULTI | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: PSYCHIATRY | ||||||
| 10/19/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: NEUROLOGY | ||||||
| 09/25/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $9.20 | General |
| Category: PSYCHIATRY | ||||||
| 09/06/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.93 | General |
| Category: PSYCHIATRY | ||||||
| 08/31/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $10.11 | General |
| Category: PSYCHIATRY | ||||||
| 08/15/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: PSYCHIATRY | ||||||
| 07/28/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: PSYCHIATRY | ||||||
| 07/14/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $12.27 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 150 | 295 | $59,874 | $21,284 |
| 2022 | 4 | 364 | 664 | $134,823 | $46,809 |
| 2021 | 8 | 499 | 1,658 | $335,302 | $117,626 |
| 2020 | 7 | 543 | 1,573 | $264,444 | $92,364 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 103 | 204 | $43,350 | $16,725 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 48 | $8,762 | $2,419 | 27.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 14 | 43 | $7,762 | $2,141 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 297 | $62,995 | $27,841 | 44.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 181 | 325 | $59,329 | $15,645 | 26.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 30 | 30 | $10,699 | $3,142 | 29.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 12 | 12 | $1,800 | $180.97 | 10.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 210 | 831 | $151,280 | $52,709 | 34.8% |
| 90834 | Psychotherapy, 45 minutes | Office | 2021 | 23 | 384 | $90,989 | $29,982 | 33.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 69 | 69 | $24,451 | $9,747 | 39.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 24 | 84 | $16,800 | $7,411 | 44.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 75 | $15,743 | $7,259 | 46.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 47 | 82 | $14,350 | $5,197 | 36.2% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 47 | 80 | $13,800 | $3,321 | 24.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 30 | 53 | $7,890 | $1,999 | 25.3% |
| 90834 | Psychotherapy, 45 minutes | Office | 2020 | 28 | 457 | $73,498 | $31,363 | 42.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 181 | 504 | $85,697 | $21,307 | 24.9% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 154 | 331 | $43,277 | $17,548 | 40.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 74 | 163 | $32,600 | $13,719 | 42.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 54 | 54 | $18,927 | $5,571 | 29.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 27 | 37 | $7,080 | $2,571 | 36.3% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 25 | 27 | $3,365 | $283.96 | 8.4% |
About Dr. Bryan Weinstein, D.O
Dr. Bryan Weinstein, D.O is a Psychiatry healthcare provider based in Livonia, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295773034.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bryan Weinstein, D.O has received a total of $15,180 in payments from pharmaceutical and medical device companies, with $206.72 received in 2024. These payments were reported across 543 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,008).
As a Medicare-enrolled provider, Weinstein has provided services to 1,556 Medicare beneficiaries, totaling 4,190 services with total Medicare billing of $278,083. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Livonia, MI
- Active Since 06/03/2006
- Last Updated 06/19/2014
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295773034
Products in Payments
- NUEDEXTA (Drug) $8,487
- REXULTI (Drug) $1,404
- LATUDA (Drug) $1,272
- Equetro (Drug) $511.29
- VRAYLAR (Drug) $506.00
- Trintellix (Drug) $401.80
- BRINTELLIX (Drug) $248.94
- VYVANSE (Drug) $198.37
- BELSOMRA (Drug) $182.88
- Evekeo (Drug) $144.25
- TRINTELLIX (Drug) $126.07
- AUSTEDO (Drug) $110.56
- NEUROSTAR TMS THERAPY SYSTEM (Device) $109.79
- ONZETRA Xsail (Drug) $99.74
- NEUROSTAR TMS THERAPY (Device) $97.85
- CAPLYTA (Drug) $91.54
- Fanapt (Drug) $90.37
- ABILIFY MAINTENA (Drug) $86.73
- UBRELVY (Drug) $84.39
- Nuedexta (Drug) $65.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Livonia
Dr. Samuel Wedes, Md, MD
Psychiatry — Payments: $155,219
Dr. Patrick Gresham, M.d, M.D
Psychiatry — Payments: $13,507
Chalakudy Ramakrishna, Md Pc, MD PC
Psychiatry — Payments: $11,893
Dr. Sridevi Kodali, M.d, M.D
Psychiatry — Payments: $8,548
Dr. Srinivasa Kodali
Psychiatry — Payments: $6,876
Debra Glitz, Md, MD
Psychiatry — Payments: $3,600